◆ SpookStack

*T : 5 . Research Proposals Tr» the light of the above, the following are planned for the coming year: 1 . Screening of tryptamine compounds in animals and man for hallucino- genic action. - •; 2. Completion of the study of the use of riboflavin as a trace chemical to prove the ingestion of medication in a clinical setting. 3. Further studies on the use of phenoxybenzamine and other adrenergic blocking compounds as antidotes to LSD-25. 4. Further refinement of the use of quantitative brain wave studies to diagnose schizophrenia and to determine the action of hallucinogens. 5. Selection of one or more of a series of stimulant diamines for chronic toxicity studies in animals so that they can be tested in normal human volunteers for possible stimulant action. 6. A search in brain extracts of rabbits treated with Tofranil (iinipra- mine) to determine if any stimulant amine accumulates as a result of degradation of the drug molecule in the body. 7. Determination of the anti-cholinesterase and aminoxidase inhibitory effect of the stimulant diamines. 8. Assay of acet>fcholine content of various portions of the brain after prolonged administration of deanol. 9. Tire assay in man of an intravenous analgesic solution composed of morphine and choline or morphine and carnitine wherein the pharma- cologically neutral quaternary compound prevents the engagement of peripheral receptors by the morphine. warning ... SOURCES Jtr.’Df.JE Ti fcpS<fNVOlVFn